Compile Data Set for Download or QSAR
maximum 50k data
Found 123 with Last Name = 'schwender' and Initial = 'cf'
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037791(4-(Hydroxy-{1-[2-(3,4,5-trimethoxy-phenyl)-benzofu...)
Affinity DataIC50:  40nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037795(CHEMBL120885 | Furan-2-carboxylic acid hydroxy-[1-...)
Affinity DataIC50:  40nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037807(CHEMBL331626 | N-[1-(2-Butyl-benzofuran-5-yl)-ethy...)
Affinity DataIC50:  50nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037803(4-{[1-(2-Butyl-benzofuran-5-yl)-ethyl]-hydroxy-car...)
Affinity DataIC50:  50nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037805(CHEMBL121025 | N-hydroxy-N-[1-[2-(3,4,5-trimethoxy...)
Affinity DataIC50:  50nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037792(CHEMBL122955 | N-Hydroxy-N-[1-(2-phenyl-benzofuran...)
Affinity DataIC50:  50nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037793(4-{Hydroxy-[1-(2-phenyl-benzofuran-5-yl)-ethyl]-ca...)
Affinity DataIC50:  60nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037788(CHEMBL421255 | N-Hydroxy-N-{1-[2-(6-methoxy-naphth...)
Affinity DataIC50:  120nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037801(4-{[1-(2-Decyl-benzofuran-5-yl)-ethyl]-hydroxy-car...)
Affinity DataIC50:  150nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037789(CHEMBL332395 | N-Hydroxy-2-methoxy-N-[1-(2-phenyl-...)
Affinity DataIC50:  160nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037796(Acetic acid {hydroxy-[1-(2-phenyl-benzofuran-5-yl)...)
Affinity DataIC50:  160nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037797(CHEMBL123396 | N-Hydroxy-3,4-dimethoxy-N-[1-(2-phe...)
Affinity DataIC50:  200nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037806(CHEMBL123177 | Thiophene-2-carboxylic acid hydroxy...)
Affinity DataIC50:  250nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037794(CHEMBL331060 | N-Hydroxy-N-{1-[2-(3,4,5-trimethoxy...)
Affinity DataIC50:  310nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50000541((+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea |...)
Affinity DataIC50:  370nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50022683(CHEMBL418304 | N-[1-(4-Benzyloxy-phenyl)-ethyl]-N-...)
Affinity DataIC50:  370nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037790(CHEMBL331881 | N-[1-(2-Decyl-benzofuran-5-yl)-ethy...)
Affinity DataIC50:  410nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037799(CHEMBL123649 | N-Hydroxy-N-[1-(4-phenethyloxy-phen...)
Affinity DataIC50:  410nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037798(CHEMBL121390 | N-hydroxy-N-[1-(2-phinyl-5-benzofur...)
Affinity DataIC50:  410nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037787(CHEMBL332814 | N-Hydroxy-N-[1-(2-phenyl-benzofuran...)
Affinity DataIC50:  490nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50022697(CHEMBL62114 | N-Hydroxy-N-{1-[4-(1-phenyl-ethoxy)-...)
Affinity DataIC50:  500nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037804(2,N-Dihydroxy-N-[1-(2-phenyl-benzofuran-5-yl)-ethy...)
Affinity DataIC50:  700nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50240513((1-Benzoyl-1-naphthalen-1-yl-2-oxo-2-phenyl-ethyl)...)
Affinity DataIC50:  1.40E+3nMAssay Description:Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curveMore data for this Ligand-Target Pair
In DepthDetails Article
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037802(CHEMBL120107 | N-Hydroxy-2,6-dimethoxy-N-[1-(2-phe...)
Affinity DataIC50:  3.00E+3nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Rattus norvegicus)
R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50037800(CHEMBL121555 | N-Hydroxy-N-[1-(2-phenyl-benzofuran...)
Affinity DataIC50:  4.83E+3nMAssay Description:In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50139758((2-Naphthalen-2-yl-1-naphthalen-1-yl-2-oxo-ethyl)-...)
Affinity DataIC50:  6.00E+3nMAssay Description:Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curveMore data for this Ligand-Target Pair
In DepthDetails Article
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Millennium Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50090113((S)-2-(2-Hydroxy-5-nitro-benzylamino)-N-(3-methyl-...)
Affinity DataIC50:  6.00E+3nMAssay Description:Inhibition of alpha-4 beta7/MAdCAM mediated cell adhesion was evaluated using B-cell lymphoma RPMI 8866 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50284958((2-Biphenyl-4-yl-1-naphthalen-1-yl-ethyl)-phosphon...)
Affinity DataIC50:  6.30E+3nMAssay Description:Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curveMore data for this Ligand-Target Pair
In DepthDetails Article
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Millennium Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50090117((S)-2-(2-Hydroxy-5-nitro-benzylamino)-3-phenyl-pro...)
Affinity DataIC50:  7.00E+3nMAssay Description:Inhibition of alpha-4 beta7/MAdCAM mediated cell adhesion was evaluated using B-cell lymphoma RPMI 8866 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Millennium Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50090108((S)-2-(2-Hydroxy-5-nitro-benzylamino)-3-phenyl-pro...)
Affinity DataIC50:  7.00E+3nMAssay Description:Inhibition of alpha-4 beta7/MAdCAM mediated cell adhesion was evaluated using B-cell lymphoma RPMI 8866 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288643(CHEMBL106132 | [Phenyl-(2-trifluoromethyl-phenyl)-...)
Affinity DataIC50:  9.00E+3nMAssay Description:Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphateMore data for this Ligand-Target Pair
In DepthDetails Article
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Millennium Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50090119((S)-2-(2-Hydroxy-5-nitro-benzylamino)-3-phenyl-pro...)
Affinity DataIC50:  9.00E+3nMAssay Description:Inhibition of alpha-4 beta7/MAdCAM mediated cell adhesion was evaluated using B-cell lymphoma RPMI 8866 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50284955(CHEMBL416111 | [1-(4-Chloro-benzyl)-2-(4-chloro-ph...)
Affinity DataIC50:  9.30E+3nMAssay Description:Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curveMore data for this Ligand-Target Pair
In DepthDetails Article
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50284954(CHEMBL53536 | [2-Cyclohexyl-1-(2-methyl-naphthalen...)
Affinity DataIC50:  1.10E+4nMAssay Description:Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curveMore data for this Ligand-Target Pair
In DepthDetails Article
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50284957((2-Cyclohexyl-1-naphthalen-1-yl-ethyl)-phosphonic ...)
Affinity DataIC50:  1.14E+4nMAssay Description:Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curveMore data for this Ligand-Target Pair
In DepthDetails Article
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50226906(CHEMBL30001)
Affinity DataIC50:  1.30E+4nMAssay Description:Inhibition of canine cardiac fraction III cAMP phosphodiesterase (PDE 3) at 1.875 mg/kg intravenous doseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288649((1,3-Diphenyl-propyl)-phosphonic acid | CHEMBL1062...)
Affinity DataIC50:  1.40E+4nMAssay Description:Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphateMore data for this Ligand-Target Pair
In DepthDetails Article
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288656((Phenyl-m-tolyl-methyl)-phosphonic acid | CHEMBL71...)
Affinity DataIC50:  1.40E+4nMAssay Description:Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphateMore data for this Ligand-Target Pair
In DepthDetails Article
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50226909(CHEMBL31133)
Affinity DataIC50:  1.40E+4nMAssay Description:Inhibitory activity against canine cardiac fraction III cyclic AMP phosphodiesterase (PDE III) at 8.75 mg/kg intravenous doseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288653(CHEMBL104125 | [(3-Chloro-phenyl)-phenyl-methyl]-p...)
Affinity DataIC50:  1.50E+4nMAssay Description:Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphateMore data for this Ligand-Target Pair
In DepthDetails Article
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288651((2-Biphenyl-4-yl-1-phenyl-ethyl)-phosphonic acid |...)
Affinity DataIC50:  1.60E+4nMAssay Description:Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphateMore data for this Ligand-Target Pair
In DepthDetails Article
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50226910(Bemarinone)
Affinity DataIC50:  1.70E+4nMAssay Description:Inhibition of canine cardiac fraction III cAMP phosphodiesterase (PDE 3) at 0.875 mg/kg intravenous doseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288665(CHEMBL322700 | [(3-Nitro-phenyl)-phenyl-methyl]-ph...)
Affinity DataIC50:  1.70E+4nMAssay Description:Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphateMore data for this Ligand-Target Pair
In DepthDetails Article
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50226908(CHEMBL30387)
Affinity DataIC50:  1.80E+4nMAssay Description:Inhibition of canine cardiac fraction III cAMP phosphodiesterase (PDE 3) at 1.875 mg/kg intravenous doseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50226905(CHEMBL1743762)
Affinity DataIC50:  1.80E+4nMAssay Description:Inhibitory activity against canine cardiac fraction III cyclic AMP phosphodiesterase (PDE III) at 8.75 mg/kg intravenous doseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50284959(CHEMBL300425 | [2-(4-Chloro-phenyl)-1-naphthalen-1...)
Affinity DataIC50:  2.10E+4nMAssay Description:Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curveMore data for this Ligand-Target Pair
In DepthDetails Article
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50284956((1-Naphthalen-1-yl-2-phenyl-ethyl)-phosphonic acid...)
Affinity DataIC50:  2.10E+4nMAssay Description:Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curveMore data for this Ligand-Target Pair
In DepthDetails Article
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50226907(CHEMBL30636)
Affinity DataIC50:  2.20E+4nMAssay Description:Inhibitory activity against canine cardiac fraction III cyclic AMP phosphodiesterase (PDE III) at 8.75 mg/kg intravenous doseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstatic acid phosphatase(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288666((9H-Xanthen-9-yl)-phosphonic acid | CHEMBL106688)
Affinity DataIC50:  2.20E+4nMAssay Description:Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphateMore data for this Ligand-Target Pair
In DepthDetails Article
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50226913(CHEMBL30542)
Affinity DataIC50:  2.50E+4nMAssay Description:Inhibitory activity against canine cardiac fraction III cyclic AMP phosphodiesterase (PDE III) at 8.75 mg/kg intravenous doseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 123 total ) | Next | Last >>
Jump to: